All Relations between Myasthenia Gravis and musk

Publication Sentence Publish Date Extraction Date Species
Silvia Falso, Marco Gessi, Sofia Marini, Roberta Benvenuto, Eleonora Sabatelli, Antonio D'Amati, Martina Marini, Amelia Evoli, Raffaele Iori. Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology. Annals of neurology. 2024-07-15. PMID:39007444. cancer frequency in musk myasthenia gravis and histological evidence of paraneoplastic etiology. 2024-07-15 2024-07-18 Not clear
Silvia Falso, Marco Gessi, Sofia Marini, Roberta Benvenuto, Eleonora Sabatelli, Antonio D'Amati, Martina Marini, Amelia Evoli, Raffaele Iori. Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology. Annals of neurology. 2024-07-15. PMID:39007444. cancer frequency in muscle-specific kinase myasthenia gravis (musk-mg) has not yet been explored and the mechanisms leading to the formation of musk igg remain elusive. 2024-07-15 2024-07-18 Not clear
Dinusha Gayathri, Shanika Nandasiri, Gamini Pathiran. A Case Report of MuSK Antibody-Positive Myasthenia Gravis. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975540. a case report of musk antibody-positive myasthenia gravis. 2024-07-08 2024-07-11 Not clear
Dinusha Gayathri, Shanika Nandasiri, Gamini Pathiran. A Case Report of MuSK Antibody-Positive Myasthenia Gravis. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975540. however, a minority of patients have antibodies against muscle-specific tyrosine kinase (musk), which is referred to as musk myasthenia gravis (musk-mg). 2024-07-08 2024-07-11 Not clear
Geke Zhu, Yongbo Ma, Han Zhou, Xiangtao Nie, Wenjing Qi, Lei Hao, Xiuming Gu. Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod. Frontiers in immunology. vol 15. 2024-06-24. PMID:38911858. myasthenia gravis with positive musk antibody often involves the bulbar muscles and is usually refractory to acetylcholinesterase inhibitors. 2024-06-24 2024-06-26 Not clear
Chi Ma, Dan Liu, Benqiao Wang, Yingying Yang, Ruixia Zh. Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities. Frontiers in pharmacology. vol 15. 2024-06-17. PMID:38881870. autoantibodies include long-lived antibodies against the acetylcholine receptor (achr), mainly of the igg1 subclass, and igg4, produced almost exclusively by short-lived plasmablasts, which are prevalent in muscle-specific tyrosine kinase (musk) myasthenia gravis. 2024-06-17 2024-06-19 Not clear
Shreya Jaiswal, Tripti Shrivastav. Advances in Understanding and Managing Myasthenia Gravis: Current Trends and Future Directions. Cureus. vol 16. issue 4. 2024-05-29. PMID:38803727. myasthenia gravis (mg) is an autoimmune illness characterized by autoantibodies against the acetylcholine receptor (achr), muscle-specific tyrosine kinase (musk), and an increasing number of extra postsynaptic proteins. 2024-05-29 2024-06-03 Not clear
Shreyashi Jha, Santosh Kumar Pendyal. MuSK Antibody-Positive Myasthenia Gravis With SARS CoV-2 Infection: A Case Report and Literature Review. Journal of clinical neuromuscular disease. vol 25. issue 4. 2024-05-21. PMID:38771234. musk antibody-positive myasthenia gravis with sars cov-2 infection: a case report and literature review. 2024-05-21 2024-05-27 Not clear
R Ricciardi, E Latini, M Guida, I Koneczny, M Lucchi, M Maestri, A De Rosa, A Vincen. Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients. Journal of the neurological sciences. vol 461. 2024-05-17. PMID:38759248. myasthenia gravis (mg) with musk antibodies (musk-mg) represents a distinct subtype with different responses to treatments compared to patients with achr antibodies, especially in terms of tolerance to acetylcholinesterase inhibitors (achei). 2024-05-17 2024-05-27 Not clear
Masakatsu Motomura, Hiroko Kitanosono, Shunsuke Yoshimura, Hirokazu Shiraish. [Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 5. 2024-05-14. PMID:38741505. reportedly, patients with muscle-specific kinase (musk) antibody-positive myasthenia gravis (mg) account for approximately 3.0% of all patients with mg in japan. 2024-05-14 2024-05-27 Not clear
Inga Koneczny, Marina Mané-Damas, Shenghua Zong, Sander De Haas, Saif Huda, Daan van Kruining, Jan Damoiseaux, Anna De Rosa, Michelangelo Maestri, Melania Guida, Peter Molenaar, Philip Van Damme, Andreas Fichtenbaum, Thomas Perkmann, Marc De Baets, Konstantinos Lazaridis, Vasiliki Zouvelou, Socrates Tzartos, Roberta Ricciardi, Mario Losen, Pilar Martinez-Martine. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression. Frontiers in immunology. vol 15. 2024-05-08. PMID:38715598. a retrospective multicenter study on clinical and serological parameters in patients with musk myasthenia gravis with and without general immunosuppression. 2024-05-08 2024-05-27 Not clear
Inga Koneczny, Marina Mané-Damas, Shenghua Zong, Sander De Haas, Saif Huda, Daan van Kruining, Jan Damoiseaux, Anna De Rosa, Michelangelo Maestri, Melania Guida, Peter Molenaar, Philip Van Damme, Andreas Fichtenbaum, Thomas Perkmann, Marc De Baets, Konstantinos Lazaridis, Vasiliki Zouvelou, Socrates Tzartos, Roberta Ricciardi, Mario Losen, Pilar Martinez-Martine. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression. Frontiers in immunology. vol 15. 2024-05-08. PMID:38715598. muscle-specific kinase (musk)- myasthenia gravis (mg) is caused by pathogenic autoantibodies against musk that correlate with disease severity and are predominantly of the igg4 subclass. 2024-05-08 2024-05-27 Not clear
Selen Ünlü, Blanca G Sánchez Navarro, Elif Cakan, Daniel Berchtold, Rafael Meleka Hanna, Secil Vural, Atay Vural, Andreas Meisel, Miriam L Fichtne. Exploring the depths of IgG4: insights into autoimmunity and novel treatments. Frontiers in immunology. vol 15. 2024-05-03. PMID:38698867. these diseases include myasthenia gravis (mg) with autoantibodies against muscle-specific tyrosine kinase (musk), nodo-paranodopathies with autoantibodies against paranodal and nodal proteins, pemphigus vulgaris and foliaceus with antibodies against desmoglein and encephalitis with antibodies against lgi1/caspr2. 2024-05-03 2024-05-05 Not clear
Olena Butenko, Stine Marie Jensen, Yvonne E Fillié-Grijpma, Robyn Verpalen, Jan J Verschuuren, Silvère M van der Maarel, Maartje G Huijbers, Jaap J Plom. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model. The European journal of neuroscience. 2024-04-23. PMID:38650308. change of voltage-gated sodium channel repertoire in skeletal muscle of a musk myasthenia gravis mouse model. 2024-04-23 2024-04-26 mouse
Olena Butenko, Stine Marie Jensen, Yvonne E Fillié-Grijpma, Robyn Verpalen, Jan J Verschuuren, Silvère M van der Maarel, Maartje G Huijbers, Jaap J Plom. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model. The European journal of neuroscience. 2024-04-23. PMID:38650308. muscle-specific kinase myasthenia gravis (musk mg) is caused by autoantibodies against musk in the neuromuscular junction (nmj). 2024-04-23 2024-04-26 mouse
Ting He, Kangzhi Chen, Yi Li, Zhaohui Luo, Mengchuan Luo, Huan Yan. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China. Neuropsychiatric disease and treatment. vol 20. 2024-04-03. PMID:38566882. to decipher the discrepancies between muscle-specific kinase antibody-positive myasthenia gravis (musk-mg) and double-seropositive myasthenia gravis (dsp-mg), and to determine prognostic factors for minimal manifestation status (mms) achievement in mg patients with musk autoantibodies (musk-ab). 2024-04-03 2024-04-05 Not clear
A Baheerathan, R Dorsey, S Viega. Oral salbutamol for symptomatic treatment in MuSK antibody-positive myasthenia gravis: a single-centre experience. Acta neurologica Belgica. 2024-04-01. PMID:38561498. oral salbutamol for symptomatic treatment in musk antibody-positive myasthenia gravis: a single-centre experience. 2024-04-01 2024-04-04 Not clear
Tadaharu Shiozumi, Nobunaga Okada, Tasuku Matsuyama, Yoshihiro Yamahata, Bon Oht. Anti-Muscle-Specific Kinase (MuSK) Antibody-Positive Myasthenia Gravis Presenting With Dyspnea in an Elderly Woman: A Case Report. Cureus. vol 15. issue 12. 2024-01-15. PMID:38222201. anti-muscle-specific kinase (musk) antibody-positive myasthenia gravis presenting with dyspnea in an elderly woman: a case report. 2024-01-15 2024-01-17 Not clear
Kazuhiro Shigemot. [Pathogenesis of MuSK Antibody-positive Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 1. 2024-01-08. PMID:38191139. [pathogenesis of musk antibody-positive myasthenia gravis]. 2024-01-08 2024-01-10 Not clear
Takayuki Kond. [Clinical Features and Pathogenesis of Double Seronegative Myasthenia Gravis]. Brain and nerve = Shinkei kenkyu no shinpo. vol 76. issue 1. 2024-01-08. PMID:38191140. subjects with double seronegative myasthenia gravis (dnmg) are defined as those who are seronegative to both antibodies against acetylcholine receptor (achr) and muscle-specific kinase (musk) by radioimmunoprecipitation assay (ria). 2024-01-08 2024-01-10 human